As demand for life sciences buildings continues to exceed availability, veteran real estate developer Howard Kozloff has launched a new real estate firm devoted to developing life science workspaces ...
Understand the fundamentals that drive life. Do basic research that leads to medical breakthroughs and improvements in our world. Study the underlying chemistry of organisms and ecosystems. Help ...
Over the past four years, private equity (PE) firms that invested in life science assets have faced a difficult reality. While many investors still debate whether some sectors of the market are in a ...
The Nature Index tracks primary research articles from 145 natural-science and health-science journals, chosen based on reputation by an independent group of researchers. The Nature Index provides ...
How much more “mega” can Alexandria Real Estate Equities add to its “mega campus” for life sciences in Seattle? Mucho mega, apparently. The Pasadena-based real estate investment trust will buy and ...
Anthropic is launching Claude for Life Sciences, a new model aimed at aiding scientific research. Through integrations with leading life sciences players, the platform will help researchers at every ...
A surge of 147% in a single session is an unusual occurrence in biotech — and nearly unprecedented for a company that has spent years trading discreetly under the radar. However, that is precisely ...
Taking a position in a life science exchange-traded fund (ETF) provides exposure to a basket of stocks focused on the healthcare sector, while mitigating the risks of holding shares in a single ...
A couple of years ago, life science companies were fighting for office leases and developers couldn’t meet the demand fast enough. But now, that hunger for square footage has diminished, and the ...
FORUM is a state-of-the-art life science building located at 60 Guest Street in the Boston Landing campus in Allston/Brighton, Massachusetts. The nine-story structure comprises 355,000 rentable square ...
Click to view our current database of Funding Opportunites in the Life Sciences. These “zombie” cells are damaged yet refuse to die. Instead, they linger in the body, infect healthy cells, and can ...